Trial intelligence / Profile preview

EDG-7500 in Adults With Hypertrophic Cardiomyopathy

NCT06347159Phase 2Active, not recruiting

Start
Apr 2024
Primary completion
Dec 2027
Countries
1
01

Overview

A Phase 2 trial of edg-7500 in hypertrophic cardiomyopathy (HCM). Started Apr 2024; status: active, not recruiting.

02

Drugs

edg-7500
03

Conditions

hypertrophic cardiomyopathy (HCM)

Beyond the preview

Go deeper on NCT06347159.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06347159.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call